Funds and ETFs PeptiDream Inc.

Equities

4587

JP3836750004

Biotechnology & Medical Research

Market Closed - Japan Exchange 02:00:00 2024-05-16 am EDT 5-day change 1st Jan Change
1,900 JPY -2.56% Intraday chart for PeptiDream Inc. -3.82% +27.78%

ETFs positioned on PeptiDream Inc.

Name Weight AuM 1st Jan change Investor Rating
1.03% 14 M€ -2.11%
0.54% 19 M€ +11.47%
0.06% 14 M€ +17.02%
0.04% 4,929 M€ +16.98%
0.04% 9,760 M€ +17.20%
0.04% 57 M€ +17.54%
0.03% 17 M€ +11.76% -
0.03% 20,360 M€ +15.77% -
0.03% 140,441 M€ +16.85%
0.03% 63,295 M€ +16.94% -
0.01% 746 M€ -.--% -
0.01% 4 M€ +17.30%
0.01% 10 M€ -3.35% -
0.01% 7 M€ +6.66% -
0.00% 32 M€ +8.77% -
0.00% 391 M€ +9.47% -
0.00% 34 M€ +9.13% -
0.00% 39 M€ +5.99% -
0.00% 306 M€ +6.92% -
0.00% 34 M€ +4.39% -
PeptiDream Inc. is a Japan-based bio-venture company started by the University of Tokyo and principally engaged in the discovery and development of non-standard peptide therapeutics. The Company operates the Peptide Discovery Platform System (PDPS), a drug development platform system and conducts research and development (R&D) on new drug candidates based on the joint R&D with pharmaceutical companies in Japan and overseas. The Company is involved in the business centered on drug development based on special peptides. The Company's businesses include drug discovery joint R&D, PDPS technology loan (PDPS technology license) and expansion of its own pipeline through strategic alliance (strategic alliance or in-house drug discovery).
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
1,900 JPY
Average target price
2,750 JPY
Spread / Average Target
+44.77%
Consensus
  1. Stock Market
  2. Equities
  3. 4587 Stock
  4. Funds and ETFs PeptiDream Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW